Defence Therapeutics Inc.
DTCFF
$0.35
-$0.02-5.41%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.12M | 690.90K | 1.67M | 903.60K | 1.45M |
| Total Receivables | 226.40K | 162.40K | 159.30K | 145.20K | 61.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.40K | 15.90K | 23.80K | 24.50K | 3.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.35M | 869.20K | 1.85M | 1.07M | 1.51M |
|
|
|||||
| Total Current Assets | 2.35M | 869.20K | 1.85M | 1.07M | 1.51M |
| Net Property, Plant & Equipment | 120.50K | 129.20K | 138.20K | 137.60K | 133.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.31M | -- | -- | -- | -- |
| Total Assets | 6.78M | 998.50K | 1.99M | 1.21M | 1.64M |
|
|
|||||
| Total Accounts Payable | 699.30K | 796.80K | 814.10K | 976.60K | 802.40K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 1.12M | 1.10M | 968.80K |
| Total Finance Division Other Current Liabilities | -- | 9.40K | 51.10K | 52.20K | 26.10K |
| Total Other Current Liabilities | -- | 9.40K | 51.10K | 52.20K | 26.10K |
| Total Current Liabilities | 699.30K | 806.20K | 1.98M | 2.13M | 1.80M |
|
|
|||||
| Total Current Liabilities | 699.30K | 806.20K | 1.98M | 2.13M | 1.80M |
| Long-Term Debt | 1.12M | 1.09M | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 1.01M | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.07M | 0.00 | -- | -- | -- |
| Total Liabilities | 2.90M | 1.89M | 3.00M | 2.13M | 1.80M |
|
|
|||||
| Common Stock & APIC | 23.61M | 18.83M | 17.37M | 17.74M | 13.87M |
| Retained Earnings | -24.61M | -22.86M | -21.55M | -21.49M | -19.70M |
| Treasury Stock & Other | 4.89M | 3.14M | 3.17M | 2.83M | 5.68M |
| Total Common Equity | 3.89M | -892.80K | -1.01M | -920.80K | -152.90K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.89M | -892.80K | -1.01M | -920.80K | -152.90K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.89M | -892.80K | -1.01M | -920.80K | -152.90K |
|
|
|||||